HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rapid Detection Of Pathogens Is High Priority In Need Of Technology

This article was originally published in The Tan Sheet

Executive Summary

FDA Associate Commissioner for Foods David Acheson says the search continues for an "out-of-the-box" technology to rapidly detect salmonella in foods starting in 2009

You may also be interested in...



FDA Strategic Documents Outline Regulatory Science Priorities

Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report

FDA Prioritizes Rapid Detection Of Food Contaminants

FDA has made a top priority of developing methods to rapidly detect food-borne contaminants and is working with other agencies to identify effective systems

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel